Senate Banking Committee Asks: Should China be Allowed to Buy U.S. Farmland?
Should China be allowed to buy U.S. farmland? What about agribusiness operations that are near military installments?
House Foreign Affairs Committee Spars Over China Export Controls
Another day, another hearing on China on Capitol Hill. The House Foreign Affairs Committee held a hearing on Feb. 28 titled “Combatting the Generational Challenge
Why an Increasing Number of U.S. States are Banning China Tech
A look at what states are banning Chinese tech companies like Lenovo, and why more are following this trend started by the state of Georgia.
Treasury Takes Car Buyers and Congress For a Ride
Last August, President Biden signed the Inflation Reduction Act, a sweeping bill that has already led to tens of billions in private investment into U.S.
Trade Deals Need to Reconsider Supply Chain Risks – GAO Report
A new report by the Government Accountability Office highlights the need for revamped trade deals. But missing from the discussion is the case for more local supply chains.
U.S. Beats Trade Deficit Record, Ends 2022 With $1.19 Trillion Goods Gap
The latest trade figures show historic deficits with Mexico, Canada and Vietnam. Meanwhile, the 2022 deficit with China and the EU is the second largest of all time.
Is the U.S. Still Financing China’s Military Might?
Yes, in many ways the U.S. is funding China’s defense sector through venture capital, portfolio investments, and computer hardware sales to companies on the Entity List.
Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?
Americas Act Addresses Key Failure of Past Trade Deals
U.S. Senator Bill Cassidy (R-LA) has released a discussion draft of a sweeping, ambitious bill titled the “Americas Act”. The bill states its aim to
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
